Overview

Aquilus Pharmaceuticals is dedicated to developing a first-in-class medication for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS). Our mission is to make a meaningful impact on patients’ lives by advancing therapeutics in this challenging field.